Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rio P Juni

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|March 19, 2013
Oxidative stress and pathological changes after coronary artery interventionsRio P Juni, Henricus J Duckers, Paul M Vanhoutte, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2012
Nitroso-redox balance in control of coronary vasomotor toneYannick J H J Taverne, Vincent J de Beer, Bas A Hoogteijling, et al.
Journal of Molecular and Cellular Cardiology|October 6, 2015
Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overloadElza D van Deel, Yanti Octavia, Martine de Boer, et al.
Communications Biology|May 7, 2024
Aging-regulated PNUTS maintains endothelial barrier function via SEMA3B suppressionNoelia Lozano-Vidal, Laura Stanicek, Diewertje I Bink, et al.
JACC. Basic to Translational Science|November 27, 2019
Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by EmpagliflozinRio P Juni, Diederik W D Kuster, Max Goebel, et al.
Kidney International|December 28, 2020
Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contractionRio P Juni, Rushd Al-Shama, Diederik W D Kuster, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 15, 2019
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial CellsLaween Uthman, Anna Homayr, Rio P Juni, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 21, 2018
FGF23 impairs peripheral microvascular function in renal failureMelissa Verkaik, Rio P Juni, Ellen P M van Loon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2023
MicroRNA-216a is essential for cardiac angiogenesisRio P Juni, Jordy M M Kocken, Ricardo C Abreu, et al.
Iscience|January 25, 2024
HDAC1/2 inhibitor therapy improves multiple organ systems in aged miceAlessandra Tammaro, Eileen G Daniels, Iman M Hu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|March 19, 2013
Oxidative stress and pathological changes after coronary artery interventionsRio P Juni, Henricus J Duckers, Paul M Vanhoutte, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2012
Nitroso-redox balance in control of coronary vasomotor toneYannick J H J Taverne, Vincent J de Beer, Bas A Hoogteijling, et al.
Journal of Molecular and Cellular Cardiology|October 6, 2015
Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overloadElza D van Deel, Yanti Octavia, Martine de Boer, et al.
Communications Biology|May 7, 2024
Aging-regulated PNUTS maintains endothelial barrier function via SEMA3B suppressionNoelia Lozano-Vidal, Laura Stanicek, Diewertje I Bink, et al.
JACC. Basic to Translational Science|November 27, 2019
Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by EmpagliflozinRio P Juni, Diederik W D Kuster, Max Goebel, et al.
Kidney International|December 28, 2020
Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contractionRio P Juni, Rushd Al-Shama, Diederik W D Kuster, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 15, 2019
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial CellsLaween Uthman, Anna Homayr, Rio P Juni, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 21, 2018
FGF23 impairs peripheral microvascular function in renal failureMelissa Verkaik, Rio P Juni, Ellen P M van Loon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2023
MicroRNA-216a is essential for cardiac angiogenesisRio P Juni, Jordy M M Kocken, Ricardo C Abreu, et al.
Iscience|January 25, 2024
HDAC1/2 inhibitor therapy improves multiple organ systems in aged miceAlessandra Tammaro, Eileen G Daniels, Iman M Hu, et al.
Pageof 3